Maniruzzaman Lab Earns Grant to Research 3D Printed COVID-19 Treatment

A man holding up a dish in a lab.
May 26, 2021
The UT College of Pharmacy’s Pharmaceutical Engineering and 3D Printing (PharmE3D) Lab earned a Texas Global Faculty Research Seed Grant for its work on patient-specific treatment of COVID-19.

Improving Health Outcomes for People Experiencing Homelessness is Focus of New Study

Five people holding cell phones and wearing masks.
April 30, 2021
Combining mobile health technology, or mHealth, and community outreach to improve the health outcomes of people experiencing homelessness is the target of a new study led by Division of Health Outcomes Associate Professor Leticia Moczygemba, Pharm.D., Ph.D., thanks to a five-year research grant from the U.S. Department of Health and Human Services Agency for Healthcare Research and Quality.

TxCORE Research Wins PhRMA Foundation Award

Three people smiling.
April 1, 2021
Three researchers from the College of Pharmacy won an award from the Pharmaceutical Research and Manufacturers of America (PhRMA) Foundation. Leticia R. Moczygemba, Pharm.D., Ph.D., Carolyn M. Brown, Ph.D. and Michael Johnsrud, Ph.D., R.Ph. were awarded $5,000 from the PhRMA Foundation for their proposal to advance racial and ethnic representation in value assessments.

Suh and PharmE3D Labs Win Fellowships for 3D Bioprinting Research

A woman smiling in front of a sign that says "Pharmacy."
March 18, 2021
Student pharmacist Johana Suh earned an undergraduate fellowship award for research on 3D bioprinted modeling of the neurodegenerative disease NPC-1, or Niemann-Pick disease type C1. Suh is a second-year Doctor of Pharmacy candidate in the UT College of Pharmacy, and serves as an undergraduate researcher in the Pharmaceutical Engineering and 3D Printing (PharmE3D) Labs led by Mo Maniruzzaman, Ph.D.

Williams Wants to Turn COVID-19 Vaccine into Powder to Help with Storage and Distribution

A powder in a vial.
November 25, 2020
Molecular Pharmaceutics and Drug Delivery Professor Robert O. (Bill) Williams III, Ph.D. talks to CBS Austin about the potential for his thin film freezing technology to increase the shelf life of COVID-19 vaccines when they become available.

H-E-B Opens New Pharmacy on UT Austin Campus

Two men holding mugs and talking.
October 21, 2020
“H-E-B has been an innovator in community pharmacy practice in Texas. The UT College of Pharmacy has a long history of collaboration with H-E-B, including training the next generation of pharmacists through internships, experiential rotations, and post-graduate residencies,” said Dean Samuel M. Poloyac. “The opening of the new pharmacy on the UT Austin campus is a wonderful opportunity to enhance our partnership. We are excited to work together on this new endeavor.”

Live Subject Testing Shows Promising Delivery Method for COVID-19 Antiviral Treatment

A microscopic image.
September 23, 2020
Live subject testing results from the Williams Lab show that dry powder inhalation could be a potent and effective delivery method of the antiviral remdesivir to treat patients affected by COVID-19.

Richburg Receives NIH Grant Award for Toxicant Injury Research

A man smiling
August 10, 2020
Associate Dean for Research and Graduate Studies John H. Richburg, Ph.D. received notice from the National Institutes of Health (NIH) awarding him a research grant for a five-year term. The NIH’s grant award for Dr. Richburg’s research totals $2,694,316.

UT 3D Printing Labs Enter Patent License Agreement to Develop Digital 3D Drug Manufacturing and Advanced Drug Delivery Systems

Patient-centric 3D printing paradigm of medicines at the point-of-care.
July 17, 2020
Assistant Professor Mo Maniruzzaman’s Pharmaceutical Engineering and 3D Printing (PharmE3D) labs have entered an agreement with UK-based CoM3D to develop digital 3D drug manufacturing and advanced drug delivery systems.

Maniruzzaman Lab Collaboration Works to Develop Patient-Focused Medicines More Efficiently

mo lab 3d printer
April 27, 2020
To meet the need to develop methods to make drugs more soluble and usable, the Maniruzzaman Lab teamed up with Advanced Material Development (AMD) to address challenges with the reduction in quantity of new drugs coming to market.